Selpercatinib-13Cd3

SL-11652

Selpercatinib-13Cd3, >98%

Synonyms : LOXO-292-13d3

IUPAC Name : 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-(methoxy-13C-d3)pyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Selpercatinib-13Cd3 is a double-labelled version of Selpercatinib. This can be used as an analytical labelled reference standard. Selpercatinib is a potent and specific RET (c-RET) inhibitor for the treatment of non-small cell lung cancer, medullary thyroid cancer, and other types of thyroid cancers.

References : Senturk R. et. al.: J. Chromatogr B Analyt. Technol Biomed Life Sci.,1147, 122131, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.